P04-10. Neutralization of Tier 1 and Tier 2 pseudoviruses by human anti-V3 monoclonal antibodies

被引：0
|
作者：
MK Gorny
C Williams
T O'Neal
AK Choudhary
K Luthra
B Wood
MS Seaman
P Nyambi
S Zolla-Pazner
机构：
[1] Pathology,
[2] New York University School of Medicine,undefined
[3] All India Institute of Medical Sciences,undefined
[4] Fred Hutchinson Cancer Research Center,undefined
[5] Beth Israel Deaconess Medical Center,undefined
[6] Veterans Affairs New York Harbor Healthcare System,undefined
来源：
Retrovirology | / 6卷
关键词：
York City; Current Standard; City Area; Cell Assay; Neutralize Activity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Two PBMC-based neutralization assays depict low reactivity of both anti-V3 monoclonal antibodies and immune sera against HIV-1 primary isolates
    Candotti, D
    Rosenheim, M
    Huraux, JM
    Agut, H
    JOURNAL OF VIROLOGICAL METHODS, 1997, 64 (01) : 81 - 93
  • [22] Human anti-HIV-1 envelope monoclonal antibodies with a low percentage of mutations have the ability to neutralize sensitive Tier 1 viruses.
    Gorny, Miroslaw
    Li, Liuzhe
    Wang, Xiao-Hong
    Williams, Constance
    Volsky, Barbara
    Seaman, Michael
    Zolla-Pazner, Susan
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [23] Production and characterization of human anti-V3 monoclonal antibodies from Indian clade C human immunodeficiency virus type-1 (HIV-1) infected patients
    Andrabi, R.
    Kurnar, R.
    Bala, M.
    Nair, A.
    Biswas, A.
    Wig, N.
    Kumar, P.
    Luthra, K.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 2 - 2
  • [24] Induction of neutralizing antibodies against tier 2 human immunodeficiency virus 1 in rhesus macaques infected with tier 1B simian/human immunodeficiency virus
    Himeno, Ai
    Ishida, Yuki
    Mori, Hiromi
    Matsuura, Kanako
    Kikukawa, Minako
    Sakawaki, Hiromi
    Miura, Tomoyuki
    ARCHIVES OF VIROLOGY, 2019, 164 (05) : 1297 - 1308
  • [25] NEUTRALIZATION OF PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES BY THE BROADLY REACTIVE ANTI-V3 MONOCLONAL-ANTIBODY, 447-52D
    CONLEY, AJ
    GORNY, MK
    KESSLER, JA
    BOOTS, LJ
    OSSORIOCASTRO, M
    KOENIG, S
    LINEBERGER, DW
    EMINI, EA
    WILLIAMS, C
    ZOLLAPAZNER, S
    JOURNAL OF VIROLOGY, 1994, 68 (11) : 6994 - 7000
  • [26] Induction of neutralizing antibodies against tier 2 human immunodeficiency virus 1 in rhesus macaques infected with tier 1B simian/human immunodeficiency virus
    Ai Himeno
    Yuki Ishida
    Hiromi Mori
    Kanako Matsuura
    Minako Kikukawa
    Hiromi Sakawaki
    Tomoyuki Miura
    Archives of Virology, 2019, 164 : 1297 - 1308
  • [27] P20-09. Worldwide epitope prevalence of crystallographically resolved anti-V3 antibodies
    J Swetnam
    S Zolla-Pazner
    TJ Cardozo
    Retrovirology, 6
  • [28] Resistance of Subtype C HIV-1 Strains to Anti-V3 Loop Antibodies
    Almond, David
    Krachmarov, Chavdar
    Swetnam, James
    Zolla-Pazner, Susan
    Cardozo, Timothy
    ADVANCES IN VIROLOGY, 2012, 2012
  • [29] Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from non-B clade HIV-1 infected individuals
    Andrabi, Raiees
    Williams, Constance
    Wang, Xiao-Hong
    Li, Liuzhe
    Choudhary, Alok K.
    Wig, Naveet
    Biswas, Ashutosh
    Luthra, Kalpana
    Nadas, Arthur
    Seaman, Michael S.
    Nyambi, Phillipe
    Zolla-Pazner, Susan
    Gorny, Miroslaw K.
    VIROLOGY, 2013, 439 (02) : 81 - 88
  • [30] Sensing of Particulate Matter (PM 2.5 and PM 10) in the Air of Tier 1, Tier 2, and Tier 3 Cities in India Using EVDHM-ARIMA Hybrid Model
    Ghosh, Annoy Kumar
    Das, Suchandan
    Dutta, Shantanu
    Mukherjee, Aranya
    IEEE SENSORS LETTERS, 2023, 7 (05)
12345